Disease-specific clinical studies and experimental host defense.
What to look for. Which disease, peptide and clinical outcome were studied? Immune modulation is not one universal effect.
Thymosin alpha-1, also called thymalfasin, is a thymic peptide studied for immune modulation. Human clinical research includes people with chronic hepatitis B, where investigators measured disease-specific treatment responses.
Evidence in this guide: Disease-specific human studies; product approval and indications vary by country.
Read the Thymosin alpha-1 guide ↗LL-37 is part of the human cathelicidin antimicrobial system. Researchers investigate immune signaling and peptide-based approaches to inflammation, including experimental LL-37-derived hybrids.
Evidence in this guide: Experimental immune research; a hybrid containing part of LL-37 differs from the complete peptide.
Read the LL-37 guide ↗